SBI Securities Co. Ltd. Purchases Shares of 3,342 Colgate-Palmolive (NYSE:CL)

SBI Securities Co. Ltd. bought a new position in Colgate-Palmolive (NYSE:CLFree Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 3,342 shares of the company’s stock, valued at approximately $304,000.

Several other institutional investors and hedge funds also recently modified their holdings of CL. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $32,000. Bernard Wealth Management Corp. acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $36,000. Finally, Roxbury Financial LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $43,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.9 %

CL stock opened at $91.87 on Thursday. The stock has a market cap of $74.56 billion, a PE ratio of 26.10, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. The firm’s 50-day simple moving average is $88.72 and its 200 day simple moving average is $95.27. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm earned $0.87 EPS. As a group, sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Analyst Upgrades and Downgrades

CL has been the topic of several recent analyst reports. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday. Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.61.

Read Our Latest Analysis on CL

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.